| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |